Myoderm has been granted a Wholesale Dealer License from the Medicines and Healthcare products Regulatory Agency (MHRA), expanding its position within the European pharmaceutical market. Myoderm has also established a new partnership with a European pharmaceutical logistics provider.
The MHRA license agreement allows Myoderm to buy, sell and distribute pharmaceuticals within the UK and facilitates more direct access to drug
manufacturers across Europe. Additionally, Myoderm’s new partnership will allow the company to offer receiving, inspection, warehousing and distribution of pharmaceutical products, providing complete control over materials obtained and distributed throughout Europe.
“Acquiring our Wholesale Dealer License and partnering with a leading European, Pharmaceutical logistics provider is critical to our continued effort to enhance our worldwide supply capabilities,” said Mike Cohen, Myoderm’s managing director.